1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).New psychoactive substances: Global markets global threats and the COVID‐19 pandemic—an update from the EU Early Warning System.https://www.emcdda.europa.eu/publications/rapid‐communication/new‐psychoactive‐substances‐global‐markets‐glocal‐threats‐and‐covid‐19‐pandemic_en. Accessed Dec 2020.
2. United Nations Office on Drugs and Crime (UNODC).United Nations Office on Drugs and Crime. Current NPS threats. Vol. III.https://www.unodc.org/documents/scientific/Current_NPS_Threats_Vol.3.pdf. Accessed 15 Oct 2020.
3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).Synthetic cannabinoids in Europe.https://www.emcdda.europa.eu/topics/pods/synthetic‐cannabinoids. Accessed 10 Aug 2021.
4. Analysis of the prevalence and coexistence of synthetic cannabinoids in “herbal high” products in Poland